Subsets of NK cells express programmed cell death protein 1 (PD-1) and cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) [6,7], which have been intensively investigated as immune checkpoint receptors for the development of novel cancer therapeutics. Here, PDCD1 is linked to cancer.